# MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)

> **NCT00837577** · PHASE3 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 133 (actual)

## Conditions studied

- Diabetes Mellitus, Non-Insulin-Dependent

## Interventions

- **DRUG:** Comparator: Placebo
- **DRUG:** Sitagliptin
- **DRUG:** Voglibose

## Key facts

- **NCT ID:** NCT00837577
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02-05
- **Primary completion:** 2010-08-11
- **Final completion:** 2010-08-11
- **Target enrollment:** 133 (ACTUAL)
- **Last updated:** 2017-05-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00837577

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00837577, "MK0431/ONO-5435 Phase III Clinical Trial -Add-on to Voglibose Study for Patients With Type 2 Diabetes Mellitus (MK0431-104)". Retrieved via AI Analytics 2026-07-17 from https://api.ai-analytics.org/clinical/NCT00837577. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*